OverviewSuggest Edit

Immunai is a company that develops a technology intended to provide treatments for oncology and auto-immune disorders. Its technology combines biology with machine-learning to unravel the immune system, enabling clinicians to view and interrogate data and derive novel conclusions on the underlying mechanisms of disease.
HQNew York, NY, US

Latest Updates

Employees (est.) (Jan 2021)41(+14%)
Cybersecurity ratingAMore

Immunai Office Locations

Immunai has an office in New York
New York, NY, US (HQ)
180 Varick St 6th fl
Show all (1)

Immunai Financials and Metrics

Summary Metrics

Founding Date


Immunai total Funding

$20 m

Immunai latest funding size

$20 m

Time since last funding

8 months ago

Immunai investors

Immunai's latest funding round in May 2020 was reported to be $20 m. In total, Immunai has raised $20 m
Show all financial metrics

Immunai Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Immunai Online and Social Media Presence

Embed Graph

Immunai News and Updates

Immunai wants to map the entire immune system and raised $20 million in seed funding to do it

Now as the company unveils itself and the $20 million in financing it has received from investors including Viola Ventures and TLV Partners, it’s going to be making a hiring push and expanding its already robust research and development activities.

Immunai Frequently Asked Questions

  • When was Immunai founded?

    Immunai was founded in 2019.

  • How many employees does Immunai have?

    Immunai has 41 employees.

  • Who are Immunai competitors?

    Competitors of Immunai include AI Medical Service, Kheiron Medical and Vara.

  • Where is Immunai headquarters?

    Immunai headquarters is located at 180 Varick St 6th fl, New York.

  • Where are Immunai offices?

    Immunai has an office in New York.

  • How many offices does Immunai have?

    Immunai has 1 office.